Customize
Quick Links
Past Events

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 26.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Celgene Corporation, Eisai Inc., Genentech, and Novartis Pharmaceuticals Corporation.
About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
Physicians’ Education Resource ®, LLC.
All rights reserved.

31st Annual Miami Breast Cancer Conference®

31st Annual Miami Breast Cancer Conference®


Agenda

Thursday, March 6, 2014 (Mini-Symposium - World Class Tumor Board)
12:50 pm Welcome Patrick I. Borgen, MD
1:10 pm Identification of Genetic Lesions in Strong Positive Family History, BRCA-Negative Patients – Multigene Panels
Faculty has not granted permission to post this presentation
Mark Robson, MD
1:30 pm Risk Reducing Mastectomy: Where Are We in 2014? Donna-Marie Manasseh, MD
1:50 pm DCIS – The Great Margin Debate Melvin J. Silverstein, MD, FACS
2:10 pm Breast Conservation in Patients with Multiple Ipsilateral Tumors
Faculty has not granted permission to post this presentation
Judy C. Boughey, MD
2:25 pm Break (45 minutes)  
3:15 pm Sentinel Node Biopsy: Before or After Neoadjuvant Chemotherapy? Eleftherios Mamounas, MD, MPH, FACS
3:35 pm Who Should Get Post-Mastectomy Radiation Therapy? Jay R. Harris, MD
3:55 pm Stage vs Biology: What Drives Adjuvant Treatment Decisions? Kathy S. Albain, MD, FACP
4:15 pm Targeting HER-2 in Metastatic Breast Cancer in 2014 Kimberly Blackwell, MD
4:35 pm Prolonging the Benefit from Estrogen Blockade in Metastatic Breast Cancer Joyce O'Shaughnessy, MD
4:50 pm Human Subjects Implications of Genomic Profiling of Tumors Joyce O'Shaughnessy, MD
5:10 pm Panel Discussion All Faculty
5:30 pm Adjourn  
6:00 pm Welcome Reception (Exhibit Hall)  
7:00 pm Poster Session (Luster Gallerie)  
     
Friday, March 7, 2014 (Morning Track - General Session)
7:50 am Welcome Patrick I. Borgen, MD
Personalizing Breast Cancer Care  
8:00 am Individualizing Therapy in Metastatic Breast Cancer Through Genomics and Proteomics Lance A. Liotta, MD, PhD
8:15 am Newer Personalized Therapies on the Horizon for Advanced Breast Cancer Debu Tripathy, MD
8:30 am Ablative Radiotherapy for Oligo-Metastatic Disease Julia White, MD
8:45 am The Great Mammography Debate Patrick I. Borgen, MD
9:15 am How Can We "Personalize" Breast Radiation Therapy? Jay R. Harris, MD
9:30 am Management of Patients With Involved Axillary Nodes J. Michael Dixon, OBE, MD
9:45 am Implications for Axillary Radiation Following Review of the ACOSOG Z-11 Trial
Faculty has not granted permission to post this presentation
Judy C. Boughey, MD
10:00 am BREAK (45 minutes)  
10:45 am Keynote Lecture : New Times, New Strategies – Maximizing the Research Investment Judith A. Salerno, MD, MS
11:15 am Genomic Profiling of Tumors and Loco-Regional Recurrence Eleftherios Mamounas, MD, MPH, FACS
11:30 am Bringing New Drugs to the Pre-Surgical Setting: Challenges and Opportunities Kathy S. Albain, MD, FACP
12:00 pm Selecting Systemic Therapy in BRCA Heterozygotes With Breast Cancer
Faculty has not granted permission to post this presentation
Mark Robson, MD
12:20 pm Panel Discussion All Faculty
12:45 pm LUNCH  
2:00 pm - 6:00 pm Breakout Sessions  
6:15 pm - 7:15 pm Get Acquainted Reception (Exhibit Hall)  
Friday, March 7, 2014 (Afternoon Session - Surgical Track) Moderator: J. Michael Dixon, MD, OBE
2:05 pm Debate: Does It Make Sense to Rename DCIS in an Attempt to Minimize Overtreatment?  
  For: Dr. Dixon For: J. Michael Dixon, MD, OBE
  Against: Dr. Borgen Against: Patrick I. Borgen, MD
2:35 pm Case Presentations – Reduction Excision: A Superior Lumpectomy (and I Will Prove It). Melvin J. Silverstein, MD, FACS
2:55 pm Neoadjuvant Strategies in DCIS Henry Kuerer, MD, PhD, FACS
3:05 pm Lateral Chest Wall Perforator Flaps in Breast Conservation
Faculty has not granted permission to post this presentation
R Douglas Macmillan, MD, MB ChB, FRCS
3:20 pm Oncoplastic Considerations in Young Women with Breast Cancer Grant W. Carlson, MD
3:35 pm Is Breast Radiation Therapy Necessary in the Elderly? Kevin Hughes, MD, FACS
3:50 pm BREAK (45 minutes)  
4:45 pm Staging the Axilla after Neoadjuvant Chemotherapy for Node-Positive Breast Cancer
Faculty has not granted permission to post this presentation
Judy C. Boughey, MD
5:00 pm Breast Density Update: What You Need to Know
Faculty has not granted permission to post this presentation
Christina Giuliano, MD
5:15 pm Extreme Breast Conservation Melvin J. Silverstein, MD, FACS
5:35 pm Panel Discussion All Faculty
6:00 pm Adjourn  
Friday, March 7, 2014 (Afternoon Session - Medical Track) Moderator: Hyman B. Muss, MD
2:05 pm Application of Proteomics to Biomarker Discovery and Individualized Therapy Lance A. Liotta, MD
2:20 pm Innovations in Neoadjuvant Therapy: Platinum in Triple-Negative; HER2-Targeted mAbs for HER2-Positive Harold J. Burstein, MD
2:35 pm Targeting HER2 in 2014: Early-Stage Breast Cancer
Faculty has not granted permission to post this presentation
Sunil Verma, MD, MSEd, FRCPC
2:50 pm What Have We Learned About the Biology of Breast Cancer from Clinical Trials? Donald L. Weaver, MD
3:05 pm Role of Genomic Profiling in Minimally Node-Positive Breast Cancer Kathy S. Albain, MD, FACP
3:20 pm Should "Adjuvant" Bisphosphonates Ever Be Used? Debu Tripathy, MD
3:35 pm Maximizing Cardiac Function on HER2-Targeted Therapy: Proactive Use of ACE Inhibitors or Beta Blockers Hyman B. Muss, MD
3:50 pm Causes and Treatments of Low Sexual Desire in Breast Cancer Survivors Leslie Schover, PhD
4:05 pm BREAK (45 minutes)  
4:50 pm How Long Do I Continue Anti-Estrogen Therapy - 5 Years, 10 Years, Forever? Harold J. Burstein, MD
5:10 pm Panel Discussion All Faculty
5:45 pm Adjourn  
     
Saturday, March 8, 2014 (Morning Track - General Session)
8:00 am Welcome Patrick I. Borgen, MD
Hyman B. Muss, MD
Quality of Life - For the Doctor and the Patient  
8:15 am Breast Cancer as a High Stress and High Volume Career Choice: Identifying and Managing Burnout Henry Kuerer, MD, PhD, FACS
8:30 am How I Assess Symptoms in Breast Cancer Survivors in a Very Busy Clinic Hyman B. Muss, MD
8:45 am Documentation in the Era of Pay-for-Performance: Information Technology and EHR Update Kevin Hughes, MD, FACS
9:00 am The Evolution and New Definition of the Medical Tort: Practicing Defensively in the EHR Era Patrick I. Borgen, MD
9:15 am Sexual Dysfunction in Women with Breast Cancer: An Internet-Based Intervention Leslie Schover, PhD
9:30 am Oncologic and Aesthetic Outcomes of Oncoplastic Breast-Conserving Surgery
Faculty has not granted permission to post this presentation
R Douglas Macmillan, MD, MB ChB, FRCS
9:45 am The New Definition of Surgical Margins Jay R. Harris, MD
10:00 am BREAK (45 minutes)  
10:45 am Chair Emeritus Keynote Lecture: Wrong Medicine: Why Do We Pursue Futile and Costly Overtreatments? Lawrence J. Schneiderman, MD
11:30 am Genetic Testing Post-Angelina Jolie and the SCOTUS Decision Ellen Matloff, MS, CGC
11:45 am A Rational Approach to MRI in Clinical Practice
Faculty has not granted permission to post this presentation
Christina Giuliano, MD
12:00 pm Current Status of Accelerated Partial-Breast Radiation Julia White, MD
12:20 pm Panel Discussion All Faculty
1:00 pm LUNCH  
2:15 pm - 6:00 pm Breakout Sessions  
6:30 pm - 7:30 pm Closing Reception (Lawn)  
Saturday, March 8, 2014 (Afternoon Session - Surgical Track) Moderator: J. Michael Dixon, MD, OBE
2:15 pm Loco-Regional Management After Neoadjuvant Chemotherapy Eleftherios Mamounas, MD, MPH, FACS
2:35 pm Coping With Radiation in Immediate and Delayed Reconstruction
Faculty has not granted permission to post this presentation
R Douglas Macmillan, MD, MB ChB, FRCS
2:50 pm Contralateral Risk-Reducing Mastectomy with Immediate Reconstruction: Added Benefits, Added Risks Grant W. Carlson, MD
3:05 pm When Is Breast ConservationTreatment for Very Early Breast Cancer Not the Best Option? Donna-Marie Manasseh, MD
3:20 pm Should We Still Be Performing IHC on All Sentinel Nodes? Donald L. Weaver, MD
3:30 pm How I Do It: Strategies for Neoadjuvant Chemotherapy - Sentinel Node Clipping for Post-Chemotherapy Identification Henry Kuerer, MD, PhD, FACS
3:50 pm Options for Breast Reconstruction With ADM and Implants: What Is Now Available
Faculty has not granted permission to post this presentation
R Douglas Macmillan, MD, MB ChB, FRCS
4:05 pm BREAK (45 minutes)  
4:50 pm Skin-Sparing Mastectomy Grant W. Carlson, MD
5:00 pm New Uses of Lipofilling in Breast Reconstruction and in the Management of Swelling (Oedema) J. Michael Dixon, MD, OBE
5:15 pm Panel Discussion All Faculty
5:45 pm Adjourn  
Saturday, March 8, 2014 (Afternoon Session - Medical Track) Moderator: Debu Tripathy, MD
2:20 pm Debate: Next-Generation Sequencing Is a Valuable Tool Today in an Oncologist's Practice  
  For: Dr. Blackwell For: Kimberly Blackwell, MD
  Against: Dr. Robson
Faculty has not granted permission to post this presentation
Against: Mark Robson, MD
3:05 pm Barriers to Fertility Preservation Before the Treatment of Breast Cancer Leslie Schover, PhD
3:20 pm How Do I Handle the Patient With an Intermediate Recurrence Score? Kimberly Blackwell, MD
3:50 pm Chemotherapy Options and Decision-Making for Advanced Breast Cancer Debu Tripathy, MD
4:05 pm Cancer Survivorship: What to Monitor and When to Intervene Hyman B. Muss, MD
4:20 pm BREAK (45 minutes)  
5:05 pm Practical Considerations in the Management of HR+ MBC: Optimizing the Use of Endocrine Therapies With or Without mTOR Blockade Hyman B. Muss, MD
5:20 pm Evolving Paradigms in HER2+ MBC: Strategies for Individualizing Therapy with Available Agents Kimberly Blackwell, MD
5:50 pm Panel Discussion
Faculty has not granted permission to post this presentation
All Faculty
6:00 pm Adjourn  
     
Sunday, March 9, 2014 (Morning Track - General Session)
8:05 am Welcome  
8:15 am What Is the Future of HER2 as a Target in Breast Cancer?
Faculty has not granted permission to post this presentation
Sunil Verma, MD, MSEd, FRCPC
8:30 am Cancer Stem Cell Update Lance A. Liotta, MD, PhD
9:00 am A Non-Hormonal Approach to Prevent Vulvovaginal Atrophy in Women with AIs Leslie Schover, PhD
9:15 am Tomosynthesis 3-D Mammography: Do You Need It in Your Practice?
Faculty has not granted permission to post this presentation
Christina Giuliano, MD
9:30 am ASCO/San Antonio Update: Medical Oncology Debu Tripathy, MD
9:45 am ASCO/San Antonio Update: Locoregional Therapy J. Michael Dixon, MD, OBE
10:05 am PANEL – Cases Submitted by Audience Members for ARS and Discussion
Faculty has not granted permission to post this presentation
Patrick I. Borgen, MD, J. Michael Dixon, MD, OBE, Hyman B. Muss, MD, Debu Tripathy, MD, Sunil Verma, MD, MSEd, FRCPC, Lance A. Liotta, MD, PhD, Leslie Schover, PhD, and Christina Giuliano, MD
11:00 am Adjourn  







Become a Member

Forgot Password?
Filter By